Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Workers' Comp
Article
Clinical Pharmacy Intervention Puts Patients First
It's not about cost, it's about injured employee safety and improved claim outcomes.
mitchell
News Release
Mitchell Introduces New Commercial Truck Estimating Solution
Insurers and repairers can now use Mitchell’s cloud-based technology for appraisals of collision-damaged passenger and specialty vehicles, mot
Workers' Comp
News Release
South Carolina Approves Fee Schedule Changes
The South Carolina Workers’ Compensation Commission approved changes to the Medical Services Provider Manual, effective April 1, 2022.
Workers' Comp
In the News
Melissa McGarry: The Great Resignation – Four Ways a Specialty Network Can Help Fill the Talent Gap
Business Insurance: “Drug Formularies Not a Top Legislative Priority this Year”
News Release
Business Insurance: “Drug Formularies Not a Top Legislative Priority this Year”
Workers' Comp
News Release
Enlyte Publishes 2022 Workers’ Compensation Technology Trends Report
SAN DIEGO—Enlyte, the parent brand of Mitchell, Genex and Coventry, today released survey results of its